Write in a clean editor, then format for Current Treatment Options in Allergy in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Current Treatment Options in Allergy is a peer-reviewed journal published by Springer Nature, covering Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Asthma and respiratory diseases.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Current Treatment Options in Allergy 12, 45–58 (2023).
Formats any DOI in Current Treatment Options in Allergy style. No sign-up. |
| Publishes research in | Allergic Rhinitis and Sensitization Food Allergy and Anaphylaxis Research Asthma and respiratory diseases Contact Dermatitis and Allergies Drug-Induced Adverse Reactions |
| ISSN | 2196-3053 |
| Citation impact (2-yr) | 1.14 |
| h-index | 29 |
| i10-index | 72 |
| Total citations | 2,828 |
| Article processing charge | $3,390 |
| Top institutions publishing here | University of California, Los Angeles |
| Journal website | www.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
PURPOSE OF REVIEW: Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting up to 20% of children and up to 5% of adults worldwide, contributing to significant disease-related morbidity in this patient cohort. Its aetiopathogenesis is underpinned by multiple factors, including genetic susceptibility, skin barrier defects, a skewed cutaneous immune response and microbiome perturbation…
RATIONALE: Subcutaneous and sublingual immunotherapy are effective for allergic rhinitis. An important question is whether allergen immunotherapy provides a sustained clinical effect after treatment cessation. In view of potential side effects, cost and the necessary patient commitment, long-term benefit is an important consideration for the recommendation of immunotherapy over standard pharmacotherapy. PURPOSE OF REVIEW: In…
Allergic diseases are among the most common health issues worldwide. Specific immunotherapy has remained the only disease-modifying treatment, but it is not effective in all patients and may cause side effects. Over the last 25 years, allergen molecules from most prevalent allergen sources have been isolated and produced as recombinant proteins. Not only are these…
